IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company’s development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
Metrics to compare | IRME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIRMEPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.4x | −4.6x | −0.6x | |
PEG Ratio | −0.01 | −0.14 | 0.00 | |
Price/Book | −1.5x | 3.5x | 2.6x | |
Price / LTM Sales | - | 5.4x | 3.3x | |
Upside (Analyst Target) | - | 114.8% | 37.9% | |
Fair Value Upside | Unlock | 5.5% | 3.7% | Unlock |